Halozyme Corp (HALO): Market Value

Graphic logo of Halozyme Inc. (HALO)

Halozyme Therapeutics (HALO) employs an asset-light strategy by licensing its ENHANZE subcutaneous delivery system, ensuring stable FCF and high margins. This daily price chart reflects a market valuation of 11.43. Effective management ensures capital return through share buybacks, while unique enzymes reduce hospital stays for oncology patients, creating monopolistic demand for these innovations.

HALO halozyme.com: Market Value in the range 07/04/2022 - 11/16/2026

Metric breakdowns and analytics for halozyme.com (HALO)

Fundamental company valuation:Halozyme Corp HALO
Product sample of Halozyme Therapeutics

Market capitalization reflects the aggregate value of all company shares, serving as an integral indicator of market confidence in asset management quality during the current economic phase. By analyzing the issuer's total market value, an investor assesses the business resilience of Halozyme Therapeutics (HALO), whose valuation is supported by unique patent barriers and exclusive contracts with global pharma behemoths, creating an insurmountable barrier to entry for competitors.

Competitors of Halozyme Therapeutics (HALO)

Market Value BeiGene Ltd ONC|Revolution Medicines Corp - Market Value|AAPG - Market Value|Market Value cgoncology.com|UroGen (URGN) - Market Value|Market Capitalization BCAX|PSNL (Personalis Genomics) - Market Capitalization|Market Valuation Erasca Corp (ERAS)|Market Capitalization DCTH|Market Capitalization ymabs.com (YMAB)|Market Value Aura Bio AURA|CADL: Market Capitalization|Accuray, Inc. - Market Capitalization|Market Value SELLAS Life Sciences Group|ACTU: Market Capitalization|Market Value citiusonc.com (CTOR)|Market Value tuhurabio.com|TARA: Market Value|Market Valuation FATE (Fate Therapeutics Corp)|WHWK (Aadi Bioscience) - Market Value|Market Capitalization TCRX (TScan Therapeutics)|CSBR - Market Valuation|XBIT: Market Valuation|Market Value CVM (cel-sci.com)|OS Therapies Inc (OSTX) - Market Value|Radiopharm Theranostics - Market Value|ARTV (Artiva Biotherapeutics Inc.) - Market Capitalization|Market Capitalization Adlai Nortye Ltd.|Market Valuation VERU (Veru)|Market Value TPST|Market Value Xilio XLO|Renovaro Inc. (RENB) - Market Value|MURA - Market Value|Market Capitalization Kairos Pharma KAPA|OKUR (OnKure Therapeutics) - Market Valuation|Market Value CytoMed (GDTC)|Market Value Curis|Market Value APLM|Market Value tharimmune.com (THAR)|Market Valuation Advanced Biomed ADVB|Genprex, Inc - Market Valuation|Market Value CLDI|sunshinebiopharma.com - Market Capitalization|Market Value XBIO (xeneticbio.com)|SLRX (Salarius Pharmaceuticals) - Market Valuation|PPBT - Market Capitalization|Market Value American Oncology Network Inc|BGNE (BeiGene) - Market Value|Market Valuation CKPT (Checkpoint Therapeutics, Inc)|ELEV - Market Value|Market Capitalization ICAD (iCAD Inc.)|Ikena (IKNA) - Market Value|NTBL: Market Valuation|VIRX - Market Capitalization|MorphoSys Corp (MOR) - Market Value|Market Valuation NAYA Bio|Market Value Ascentage Pharma Group